Kamis, 04 Juni 2026 - 06:26 WIB

Find and Follow Us

Global Markets

IHSG 5,941.07 -4.11%

S&P 500 7,553.68 -0.74%

NASDAQ 26,853.98 -0.89%

Dow Jones 50,687.07 -1.21%

FTSE 100 10,332.30 -0.40%

CAC 40 8,150.42 -0.71%

Nikkei 225 68,402.13 +2.50%

Hang Seng 25,633.21 -1.56%

Shanghai 4,083.97 +0.22%

KOSPI 8,801.49 +0.15%

STI 5,138.24 +0.80%

ASX 200 8,785.70 +0.70%

Sensex 74,346.17 -0.41%

Gold 4,473.60 -0.35%

Silver 73.26 -2.72%

Oil (WTI) 95.35 +1.70%

Brent 97.17 +1.22%

Copper 6.48 -2.49%

Gas Alam 3.24 +2.31%

Bitcoin 64,285.01 -3.63%

Ethereum 1,814.76 -2.31%

USD/IDR 17,926.00 +0.38%

EUR/USD 1.16 -0.11%

Advertisement

Dokter Nova Yundiarto MD (IIT) Daewoong Pharmaceutical.

Dokter Nova Yundiarto MD Investigator-Initiated Trial (IIT) Yang Pertama Mengenalkan Fexuprazan Mengobati…

Redaksi • 26 April 2025

Latest Updates

- Advertisement -

Dokter Nova Yundiarto MD (IIT) Daewoong Pharmaceutical.

13:11 WIB • 26 April 2025

Dokter Nova Yundiarto MD Investigator-Initiated Trial (IIT) Yang Pertama Mengenalkan Fexuprazan Mengobati GERD di Indonesia

Diawali kariernya sebagai Dokter dan berorientasi di bidang kedokteran klinis, manajemen layanan kesehatan, dan kewirausahaan…